To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
To stay competitive in life science and medtech, it is key that you have an explicit focus on costs throughout your value chain.
The life science industry is facing multiple global challenges, e.g. increasing innovation pressure, increasing regulatory demands, capacity shortages, distribution of power and changing customer preferences for more on-demand educational engagements.
To overcome these challenges, companies in the industry need to revitalise and implement new operating models from early discovery to lifecycle management of inline brands. They need to foster innovation and new partnership models across the value chain while effectively executing complex transformations of new innovative operating models. .
We help life science companies execute increasingly complex business transformations.
We helped a global pharma company define, develop and anchor the future frontline capabilities needed to outperform competition and ensure continued profitable growth in all regions.
A global pharma company wanted to improve patients’ treatment due to significant disease management challenges. We used a patient support programme to improve treatment adherence and patient health
We helped a global TA franchise shape the future operating model in a global franchise business unit to create a highly engaged team and a cultural movement to pave the way for new therapy areas.
The aim of the project was to design the global distribution setup, including identifying and assessing the right partners for setting up two regional distribution centres, scoping the collaboration and negotiating the agreements.
Through the acquisition of an established portfolio, the pharmaceutical company has increased their presence from a single market to 20+ markets covering the US, the EU, Asia and Oceania
A Danish leader in the pharmaceutical industry acquired a new product portfolio and a manufacturing site to be integrated into the existing business.
The aim of the project was to enable a smooth transition in the supply chain and distribution track while ensuring supply continuity across all markets.
The aim of the project was to identify similarities in processes and procedures, get rid of any ambiguity and simplify. Using machine learning, all standard operating procedures were analysed for duplicates, contradictions or similarities, resulting in a significant reducing in procedural complexity.
The aim of the project was to significantly modernize the work with documents across business function by introducing a modern, easy to use system, facilitating the business process with life science native workflows and provide continuous innovation, leading to reductions in time to retrieve data and training efforts.
